Statements (26)
Predicate | Object |
---|---|
gptkbp:instanceOf |
recombinant follicle-stimulating hormone
|
gptkbp:administeredBy |
subcutaneous injection
|
gptkbp:approvedBy |
gptkb:European_Union
gptkb:European_Medicines_Agency |
gptkbp:ATCCode |
G03GA10
|
gptkbp:brand |
gptkb:Rekovelle
|
gptkbp:CASNumber |
9002-68-0
|
gptkbp:contraindication |
primary ovarian failure
ovarian enlargement tumors of the hypothalamus or pituitary gland |
https://www.w3.org/2000/01/rdf-schema#label |
follitropin delta
|
gptkbp:indication |
infertility treatment
|
gptkbp:legalStatus |
Rx-only
|
gptkbp:macromoleculeType |
gptkb:protein
|
gptkbp:mechanismOfAction |
stimulates ovarian follicular growth
|
gptkbp:pregnancyCategory |
contraindicated
|
gptkbp:prescriptionStatus |
prescription only
|
gptkbp:producedBy |
gptkb:Novo_Nordisk
|
gptkbp:routeOfAdministration |
subcutaneous
|
gptkbp:sideEffect |
abdominal pain
headache ovarian hyperstimulation syndrome |
gptkbp:usedFor |
assisted reproductive technology
controlled ovarian stimulation |
gptkbp:bfsParent |
gptkb:Rekovelle
|
gptkbp:bfsLayer |
6
|